Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02510937 · ClinicalTrials.gov registry record · Phase 1
Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis
A Phase 1 study, sponsored by Celgene.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT02510937 is a Phase 1 study that has completed, run by Celgene. The registered enrollment target is 16 participants.
The verdict
NCT02510937, a Phase 1 study, has completed, sponsored by Celgene.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Participation in the study will last for 3months, with a 1 month screening phase.
Interventions
- DRUG CC-90001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-08-05 |
| Est. Completion | 2017-02-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02510937
The ClinicalTrials.gov registry entry for NCT02510937 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Celgene, which has 308 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CC-90001 is the first listed.
NCT02510937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02510937 about?
NCT02510937 is a clinical study titled "Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis". Participation in the study will last for 3months, with a 1 month screening phase.
What is the current status of trial NCT02510937?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2015-08-05. Estimated completion is 2017-02-06.
What interventions are being tested in trial NCT02510937?
The interventions under investigation include: CC-90001 (DRUG).
Who is sponsoring clinical trial NCT02510937?
This trial is sponsored by Celgene, which has 308 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.